Mentice AB (MNTC)

Currency in SEK
16.95
+0.45(+2.73%)
Closed·
MNTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.7017.60
52 wk Range
12.0018.95
Key Statistics
Prev. Close
16.95
Open
16.9
Day's Range
16.7-17.6
52 wk Range
12-18.95
Volume
17.32K
Average Volume (3m)
11.87K
1-Year Change
27.4436%
Book Value / Share
3,93
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MNTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.00
Upside
+35.69%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Mentice AB News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 23.00
(+35.69% Upside)

Mentice AB Earnings Call Summary for Q3/2026

  • Mentice Q3 sales rose 2.9% YoY to SEK 73M; order intake surged 27% to record SEK 73M, but stock fell 8.77% on profitability concerns.
  • EBITDA turned negative at SEK -6M vs. SEK 7.7M prior year, pressured by SEK 8.5M in one-off personnel and external cost adjustments.
  • Order book grew 35% YoY to SEK 132M with SEK 43M scheduled for Q4 delivery; management attributed revenue delays to hospital timing, not lost demand.
  • No formal guidance issued, but executives expect 20% revenue growth with OPEX rising 25-50% of incremental sales to drive EBITDA improvement.
  • Geographic growth balanced: Americas +8%, APAC +29%, EMEA +9% on rolling 12-month basis; Healthcare Systems showing early traction from new hires.
Last Updated: 2026/11/10, 11:36
Read Full Transcript

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0,50 / -0,10
Revenue / Forecast
72,8M / 78,3M
EPS Revisions
Last 90 days

MNTC Income Statement

Compare MNTC to Peers and Sector

Metrics to compare
MNTC
Peers
Sector
Relationship
P/E Ratio
−25.7x−0.1x−0.2x
PEG Ratio
−0.440.020.00
Price/Book
4.3x1.5x2.6x
Price / LTM Sales
1.6x2.5x2.7x
Upside (Analyst Target)
35.7%938.1%69.6%
Fair Value Upside
Unlock31.1%11.7%Unlock

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, extensions and add-ons, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Right Heart Cath app, a mobile solution for interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; research and development services; and professional support services for installation, training, and warranty services. It operates in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.

Employees
111
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
599,19K2,13%10,13M
Other Institutional Investors
15,63M55,57%264,16M
Public Companies & Retail Investors
11,90M42,30%201,04M
Total
28,13M100,00%475,32M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gulf Offshore Limited28,73%8 081 300136 574
Bure Equity AB (publ)13,37%3 761 65963 572

FAQ

What Is the Mentice (MNTC) Stock Price Today?

The Mentice stock price today is 16,95 SEK.

What Stock Exchange Does Mentice Trade On?

Mentice is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Mentice?

The stock symbol for Mentice is "MNTC."

What Is the Mentice Market Cap?

As of today, Mentice market cap is 476,73M SEK.

What Is Mentice's Earnings Per Share (TTM)?

The Mentice EPS (TTM) is -0,66.

When Is the Next Mentice Earnings Date?

Mentice will release its next earnings report on Feb 18, 2027.

From a Technical Analysis Perspective, Is MNTC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Mentice Stock Split?

Mentice has split 0 times.

How Many Employees Does Mentice Have?

Mentice has 111 employees.

What is the current trading status of Mentice (MNTC)?

As of Nov 19, 2026, Mentice (MNTC) is trading at a price of 16,95 SEK, with a previous close of 16,95 SEK. The stock has fluctuated within a day range of 16,70 SEK to 17,60 SEK, while its 52-week range spans from 12,00 SEK to 18,95 SEK.

What Is Mentice (MNTC) Price Target According to Analysts?

The average 12-month price target for Mentice is 23,00 SEK, with a high estimate of 30 SEK and a low estimate of 16 SEK. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +35,69% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.